Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Emergent Group Inc. (“Emergent” or the “Company”) (AMEX: LZR) concerning the proposed acquisition of the Company by Universal Hospital Services, Inc. (“UHS”). Under the terms of the offer, Emergent shareholders will receive $8.46 in cash for each share they own in a transaction valued as approximately $70 million, including the assumption of debt, and is expected to close in the middle of 2011. The investigation is focused on the potential unfairness of the consideration to Emergent shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among Emergent Board members. Officers and directors holding approximately 47% of Emergent’s current outstanding voting stock have agreed to tender their shares in the proposed offer. Moreover, according to the press release, if 65% of the outstanding shares are tendered, the merger agreement allows UHS to take the necessary steps to obtain the additional shares necessary to complete the transaction. If you are interested in discussing your rights as an Emergent shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at email@example.com. Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers. To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.